Unknown

Dataset Information

0

DNA methylation of the BRD2 promoter is associated with juvenile myoclonic epilepsy in Caucasians.


ABSTRACT: OBJECTIVE:Juvenile myoclonic epilepsy (JME) is a common adolescent-onset genetic generalized epilepsy (GGE) syndrome. Multiple linkage and association studies have found that BRD2 influences the expression of JME. The BRD2-JME connection is further corroborated by our murine model; Brd2 haploinsufficiency produces characteristics that typify the clinical hallmarks of JME. Neither we, nor several large-scale studies of JME, found JME-related BRD2 coding mutations. Therefore, we investigated noncoding BRD2 regions, seeking the origin of BRD2's JME influence. BRD2's promoter harbors a JME-associated single nucleotide polymorphism (rs3918149) and a CpG (C-phosphate-G dinucleotides) island (CpG76), making it a potential "hotspot" for JME-associated epigenetic variants. Methylating promoter CpG sites causes gene silencing, often resulting in reduced gene expression. We tested for differences in DNA methylation at CpG76 in 3 different subgroups: (1) JME patients versus their unaffected family members, (2) JME versus patients with other forms of GGE, and (3) Caucasian versus non-Caucasian JME patients. METHODS:We used DNA pyrosequencing to analyze the methylation status of 10 BRD2 promoter CpG sites in lymphoblastoid cells from JME patients of Caucasian and non-Caucasian origin, unaffected family members, and also non-JME GGE patients. We also measured global methylation levels and DNA methyl transferase 1 (DNMT1) transcript expression in JME families by standard methods. RESULTS:CpG76 is highly methylated in JME patients compared to unaffected family members. In families with non-JME GGE, we found no relationship between promoter methylation and epilepsy. In non-Caucasian JME families, promoter methylation was mostly not associated with epilepsy. This makes the BRD2 promoter a JME-specific, ethnicity-specific, differentially methylated region. Global methylation was constant across groups. SIGNIFICANCE:BRD2 promoter methylation in JME, and the lack of methylation in unaffected relatives, in non-JME GGE patients, and in non-Caucasian JME, demonstrate that methylation specificity is a possible seizure susceptibility motif in JME risk and suggests JME therapeutics targeting BRD2.

SUBMITTER: Pathak S 

PROVIDER: S-EPMC5934302 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

DNA methylation of the BRD2 promoter is associated with juvenile myoclonic epilepsy in Caucasians.

Pathak Shilpa S   Miller James J   Morris Emily C EC   Stewart William C L WCL   Greenberg David A DA  

Epilepsia 20180402 5


<h4>Objective</h4>Juvenile myoclonic epilepsy (JME) is a common adolescent-onset genetic generalized epilepsy (GGE) syndrome. Multiple linkage and association studies have found that BRD2 influences the expression of JME. The BRD2-JME connection is further corroborated by our murine model; Brd2 haploinsufficiency produces characteristics that typify the clinical hallmarks of JME. Neither we, nor several large-scale studies of JME, found JME-related BRD2 coding mutations. Therefore, we investigat  ...[more]

Similar Datasets

| S-EPMC1180366 | biostudies-literature
| S-EPMC4209120 | biostudies-literature
| S-EPMC5879545 | biostudies-literature
| S-EPMC6746890 | biostudies-literature
| S-EPMC4299970 | biostudies-literature
| S-EPMC8861057 | biostudies-literature
| S-EPMC9201996 | biostudies-literature
| S-EPMC6698679 | biostudies-literature
| S-EPMC3348847 | biostudies-other
| S-EPMC4607268 | biostudies-literature